The past five years for Anika Therapeutics (NASDAQ:ANIK) investors has not been profitable
yahoo.com
news
2022-10-17 17:13:26

Statistically speaking, long term investing is a profitable endeavour. But that doesn't mean long term investors can avoid big losses. Zooming in on an example, the Anika Therapeutics, Inc. (NASDAQ:ANIK) share price dropped 60% in the last half decade. That's an unpleasant experience for long term holders. We also note that the stock has performed poorly over the last year, with the share price down 43%.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.
